Form 4 for CLPT ClearPoint Neuro, Inc.

Accepted 2026-09-03 18:22:12 ET · period of report 2026-09-02 · accession 0001193125-26-382208 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-09-03 18:22	2026-09-02	CLPT	BURNETT JOSEPH	CEO, Pres, Dir	M - OptEx	$3.47	+12.5K	130.7K	+11%	+$43.4K
D	2026-09-03 18:22	2026-09-02	CLPT	BURNETT JOSEPH	CEO, Pres, Dir	M - OptEx	$0.00	-12.5K	61.9K	-17%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-02	M	A	12,517	$3.47	130,720	D	—	—	(F1) Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
2	Derivative	Stock Options (right to buy)	2026-09-02	M	D	12,517	$0.00	61,887	D	$3.47 · — to 2029-08-15	12,517 Common Stock	(F1) Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction. (F3) The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019.